This joint press statement was issued by Health Action International and Third World Network
Joint Press Statement | 11 May 2010 | Download PDF
As an intergovernmental body focused on health, there are serious concerns about the World Health Organization’s (WHO) participation in, and endorsement of the International Medical Product Anti-Counterfeit Taskforce (IMPACT). IMPACT has been identified as an intellectual property (IP) enforcement initiative, operating outside the purview of WHO member states and it fails to address the root causes of the proliferation of medicines with compromised quality and safety, such as high medicines prices.